U.S. markets closed

Avid Bioservices, Inc. (CDMO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
31.46-0.11 (-0.35%)
At close: 1:00PM EST
30.50 -0.96 (-3.05%)
After hours: 03:17PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close31.57
Bid30.74 x 800
Ask31.57 x 1000
Day's Range30.83 - 32.36
52 Week Range8.52 - 34.51
Avg. Volume932,004
Market Cap1.93B
Beta (5Y Monthly)2.29
PE Ratio (TTM)294.02
EPS (TTM)0.11
Earnings DateNov 30, 2021 - Dec 06, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-45% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CDMO

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Avid Bioservices, Inc.
    CDMO: Lowering target price to $33.00AVID BIOSERVICES INC has an Investment Rating of HOLD; a target price of $33.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • Zacks

    Avid Bioservices (CDMO) Earnings Expected to Grow: What to Know Ahead of Q2 Release

    Avid Bioservices (CDMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire

    Avid Bioservices Appoints Elie G. Hanania, Ph.D., as Vice President, Process Development, Viral Vector Technologies

    Seasoned Life Science Industry Executive with More Than 30 Years of Experience in Cell and Gene Therapy, Including Senior Level Viral Vector Development Positions with Fujifilm Diosynth Biotechnologies and Millipore SigmaTUSTIN, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechno

  • Motley Fool

    Why Avid Bioservices Stock Surged 14% Today

    The stock market's relatively smaller companies dream of inclusion on a major equity index, as it raises their visibility and puts them on the radar of index funds. Tuesday was Avid Bioservices' (NASDAQ: CDMO) turn in the spotlight. Effective prior to the start of trading this Friday, Oct. 29, Avid will join the S&P SmallCap 600 index.